Voyant Bio
PrivateLast Round
Accelerator
Dec 2, 2024
Total Funding Raised
$150,000
Company Overview
Voyant Bio operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was an Accelerator round in December 2024.
Voyant Bio is a biotechnology company that develops AI-powered spatial biology platforms to design precision immunotherapies for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Voyant Bio Comparables
Compare Voyant Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Portrai | 87% | |
| PredxBio, Inc. | 86% | |
| Noetik | 83% |
For institutional investors. Book with your work email.
Voyant Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Voyant Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Merck Global Health Innovation Fund | Accelerator |
| Consortium Québécois sur la découverte du médicament | Accelerator |
| Northpond Ventures | Accelerator |
| McKesson Ventures | Accelerator |
| Merck Digital Sciences Studio | Accelerator |
| New Jersey Innovation Institute | Accelerator |
| The Venture Collective | Accelerator |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2025
Grew 43% QoQ, from 7 to 10 employees.
- Jun 3, 2025
Grew 600% QoQ from 1 to 7 employees.
For institutional investors. Book with your work email.
Voyant Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Voyant Bio's valuation, stock price, and market status.
Is Voyant Bio a public or private company?
Voyant Bio is a private company.
What is the current stock price of Voyant Bio?
Voyant Bio is a private company, so its shares have no public market price. Caplight tracks Voyant Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Voyant Bio worth (valuation)?
Valuation information for Voyant Bio is not publicly available.
Can I buy Voyant Bio stock?
Voyant Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Voyant Bio's last funding round?
Voyant Bio's most recent funding round was Accelerator on December 2, 2024.
Who are the main investors in Voyant Bio?
Key investors in Voyant Bio include Merck Global Health Innovation Fund, Consortium Québécois sur la découverte du médicament, Northpond Ventures, McKesson Ventures, Merck Digital Sciences Studio.
Will Voyant Bio IPO soon?
No public IPO plans have been announced for Voyant Bio.
How can I track Voyant Bio secondary market activity?
Caplight tracks bids, offers, and trades in Voyant Bio's shares on secondary markets.